title: HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells.
abstract: The highly invasive behavior of glioblastoma cells contributes to the morbidity and mortality associated with these tumors. The integrin-mediated adhesion and migration of glioblastoma cells on brain matrix proteins is enhanced by stimulation with growth factors, including platelet-derived growth factor (PDGF). As focal adhesion kinase (FAK), a nonreceptor cytoplasmic tyrosine kinase, has been shown to promote cell migration in various other cell types, we analysed its role in glioblastoma cell migration. Forced overexpression of FAK in serum-starved glioblastoma cells plated on recombinant (rec)-osteopontin resulted in a twofold enhancement of basal migration and a ninefold enhancement of PDGF-BB-stimulated migration. Both expression of mutant FAK(397F) and the downregulation of FAK with small interfering (si) RNA inhibited basal and PDGF-stimulated migration. FAK overexpression and PDGF stimulation was found to increase the phosphorylation of the Crk-associated substrate (CAS) family member human enhancer of filamentation 1 (HEF1), but not p130CAS or Src-interacting protein (Sin)/Efs, although the levels of expression of these proteins was similar. Moreover downregulation of HEF1 with siRNA, but not p130CAS, inhibited basal and PDGF-stimulated migration. The phosphorylated HEF1 colocalized with vinculin and was associated almost exclusively with 0.1% Triton X-100 insoluble material, consistent with its signaling at focal adhesions. FAK overexpression promoted invasion through normal brain homogenate and siHEF1 inhibited this invasion. Results presented here suggest that HEF1 acts as a necessary and specific downstream effector of FAK in the invasive behavior of glioblastoma cells and may be an effective target for treatment of these tumors.
authors.affiliation: Department of Pathology, Division of Neuropathology, University of Alabama at Birmingham, 35294-0007, USA.
authors.forename: M
authors.initials: M
authors.lastname: Natarajan
authors.forename: J E
authors.initials: JE
authors.lastname: Stewart
authors.forename: E A
authors.initials: EA
authors.lastname: Golemis
authors.forename: E N
authors.initials: EN
authors.lastname: Pugacheva
authors.forename: K
authors.initials: K
authors.lastname: Alexandropoulos
authors.forename: B D
authors.initials: BD
authors.lastname: Cox
authors.forename: W
authors.initials: W
authors.lastname: Wang
authors.forename: J R
authors.initials: JR
authors.lastname: Grammer
authors.forename: C L
authors.initials: CL
authors.lastname: Gladson
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D001932:Brain Neoplasms / Q000378:metabolism / Q000473:pathology*; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000502:physiology*; D051417:Focal Adhesion Kinase 1 / Q000378:metabolism*; D005909:Glioblastoma / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D015151:Immunoblotting; D009361:Neoplasm Invasiveness / Q000473:pathology*; D010750:Phosphoproteins / Q000378:metabolism*; D010766:Phosphorylation; D010982:Platelet-Derived Growth Factor / Q000378:metabolism; D034741:RNA, Small Interfering
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C099942:NEDD9 protein, human; D010750:Phosphoproteins; D010982:Platelet-Derived Growth Factor; D034741:RNA, Small Interfering; D051417:Focal Adhesion Kinase 1; C496050:PTK2 protein, human